WHO decision improves children’s access to safer polio vaccine

The novel type 2 oral polio vaccine (nOPV2), developed by a team including scientists from the Medicines and Healthcare products Regulatory Agency (MHRA), has today (9 January) been quality-assured (prequalified) by the Worl…